Immunological detection of changes in genomic DNA methylation during early zebrafish development

Genome ◽  
2007 ◽  
Vol 50 (8) ◽  
pp. 778-785 ◽  
Author(s):  
Amy B. MacKay ◽  
Aizeddin A. Mhanni ◽  
Ross A. McGowan ◽  
Patrick H. Krone

DNA methylation reprogramming, the erasure of DNA methylation patterns shortly after fertilization and their reestablishment during subsequent early development, is essential for proper mammalian embryogenesis. In contrast, the importance of this process in the development of non-mammalian vertebrates such as fish is less clear. Indeed, whether or not any widespread changes in DNA methylation occur at all during cleavage and blastula stages of fish in a fashion similar to that shown in mammals has remained controversial. Here we have addressed this issue by applying the techniques of Southwestern immunoblotting and immunohistochemistry with an anti–5-methylcytosine antibody to the examination of DNA methylation in early zebrafish embryos. These techniques have recently been utilized to demonstrate that development-specific changes in genomic DNA methylation also occur in Drosophila melanogaster and Dictyostelium discoideum , both organisms for which DNA methylation was previously not thought to occur. Our data demonstrate that genome-wide changes in DNA methylation occur during early zebrafish development. Although zebrafish sperm DNA is strongly methylated, the zebrafish genome is not detectably methylated through cleavage and early blastula stages but is heavily remethylated in blastula and early gastrula stages.

Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 391-391
Author(s):  
Amber Hogart ◽  
Subramanian S. Ajay ◽  
Hatice Ozel Abaan ◽  
Stacie M. Anderson ◽  
Elliott H. Margulies ◽  
...  

Abstract Abstract 391 DNA methylation is a reversible epigenetic modification that is required for proper mammalian development and is proposed to contribute to the pathogenesis of hematologic diseases including leukemia and bone marrow failure syndromes. Elucidating the pathways and genes regulated by DNA methylation during hematopoiesis may reveal new therapeutic targets for disease. Because the phenotype and activity of hematopoietic stem cells (HSC) and hematopoietic progenitor cells of many different lineages have been defined by both in vitro and in vivo assays, hematopoiesis is an excellent model for investigating epigenomic changes during differentiation. HSCs have the ability to self-renew and to generate blood cells of all lineages, which allows them to repopulate recipients after stem cell transplantation. The common myeloid progenitor (CMP) gives rise to all myeloid cell types including neutrophils, monocytes, platelets, and red blood cells, but cannot self renew or repopulate. In contrast to the multipotent HSC and CMP, erythroblasts (ERY) are terminally committed cells that become mature enucleated red blood cells. These three cell types represent unique stages of lineage commitment with distinct transcriptional programs, and potentially unique epigenomic signatures. In contrast to human HSC, which are defined by the absence of several cell surface markers, mouse HSC have the cell surface phenotype of lineage marker negative (Lin-) c-kit+ Sca-1+ and can be positively selected. For this reason we chose the mouse model for genome-wide methylation profiling. Murine HSC and CMP (Lin- c-kit+ Sca-1-) cells were enriched from adult mouse bone marrow with flow cytometry. Erythroblasts (CD71+/Ter119+) were positively selected from E13.5 mouse fetal livers. Genomic DNA isolated from each enriched cell population was sheared to 200-300 bp fragments. MBD2, one of five endogenous mammalian methyl CpG binding domain proteins, binds methylated DNA sequences with broad affinity. Methylated DNA fragments were enriched from the genomic DNA using a tagged, recombinant MBD2 pulldown kit (Active Motif). After pulldown, enrichment of known methylated sequences regulating the imprints of Snrpn and Rasgrf was validated by qPCR. Two biological replicates of HSC, CMP, and ERY methylated sequences and negative control supernatant fractions were submitted for high-throughput sequencing with the Illumina Genome Analyzer platform. Raw sequence data containing 32-46 × 106 reads of 36-50 base pairs were obtained for each sample. The Eland program was used to map 41-59% of reads to unique sequences in the mouse genome. Model-based Analysis of ChIP-Seq (MACS) was used to estimate the mean and variance of the sequence tag distribution across the genome and define peaks below the significance threshold of p<10-5. The number of methylation peaks decreased as cells differentiated, with 64,000 peaks identified in HSC (24,000 unique), 41,000 peaks in CMP (2000 unique), and 23,000 peaks in ERY (1000 unique). Approximately 20,000 peaks were common between all cell types with 57% of these peaks residing in RefSeq genes, 8% in regions adjacent to RefSeq genes (<10 kb), and 35% of methylation peaks in intergenic regions. Comparison of HSC expression data from Akashi et al (Blood 101: 383, 2003) to our HSC genic methylation peaks revealed that 2/3 of HSC genic peaks are within transcriptionally silent genes while 1/3 of HSC genic peaks are within expressed genes. Although DNA methylation is often associated with gene silencing, the important developmental gene Gata2 contains methylation peaks in HSC and CMP, cells that express Gata2, that are absent in ERY, where Gata2 is repressed. A Gata1-Fog1-Mbd2 complex has been described by Rodriguez et al (EMBO 24: 2354, 2005), therefore providing a link between DNA methylation and proteins known to bind at the Gata2 locus. Grass et al (Mol. Cell. Biol. 26:7056, 2006) determined that Gata2 is regulated by long-range interactions of GATA protein complexes, and consistent with this observation, distinct methylation patterns are observed up to 100 kb upstream of the Gata2 gene. Our genome-wide analysis supports an association of methylation with gene silencing but also suggests that DNA methylation is a dynamic epigenetic mark that influences hematopoietic differentiation. The changes in DNA methylation we observe around Gata2 may also contribute to long-range chromatin organization. Disclosures: No relevant conflicts of interest to declare.


2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Todd R. Robeck ◽  
Zhe Fei ◽  
Ake T. Lu ◽  
Amin Haghani ◽  
Eve Jourdain ◽  
...  

AbstractThe development of a precise blood or skin tissue DNA Epigenetic Aging Clock for Odontocete (OEAC) would solve current age estimation inaccuracies for wild odontocetes. Therefore, we determined genome-wide DNA methylation profiles using a custom array (HorvathMammalMethyl40) across skin and blood samples (n = 446) from known age animals representing nine odontocete species within 4 phylogenetic families to identify age associated CG dinucleotides (CpGs). The top CpGs were used to create a cross-validated OEAC clock which was highly correlated for individuals (r = 0.94) and for unique species (median r = 0.93). Finally, we applied the OEAC for estimating the age and sex of 22 wild Norwegian killer whales. DNA methylation patterns of age associated CpGs are highly conserved across odontocetes. These similarities allowed us to develop an odontocete epigenetic aging clock (OEAC) which can be used for species conservation efforts by provide a mechanism for estimating the age of free ranging odontocetes from either blood or skin samples.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Wardah Mahmood ◽  
Lars Erichsen ◽  
Pauline Ott ◽  
Wolfgang A. Schulz ◽  
Johannes C. Fischer ◽  
...  

AbstractLINE-1 hypomethylation of cell-free DNA has been described as an epigenetic biomarker of human aging. However, in the past, insufficient differentiation between cellular and cell-free DNA may have confounded analyses of genome-wide methylation levels in aging cells. Here we present a new methodological strategy to properly and unambiguously extract DNA methylation patterns of repetitive, as well as single genetic loci from pure cell-free DNA from peripheral blood. Since this nucleic acid fraction originates mainly in apoptotic, senescent and cancerous cells, this approach allows efficient analysis of aged and cancerous cell-specific DNA methylation patterns for diagnostic and prognostic purposes. Using this methodology, we observe a significant age-associated erosion of LINE-1 methylation in cfDNA suggesting that the threshold of hypomethylation sufficient for relevant LINE-1 activation and consequential harmful retrotransposition might be reached at higher age. We speculate that this process might contribute to making aging the main risk factor for many cancers.


2017 ◽  
Vol 55 (1) ◽  
pp. 793-803 ◽  
Author(s):  
Wenbiao Xiao ◽  
Yuze Cao ◽  
Hongyu Long ◽  
Zhaohui Luo ◽  
Shuyu Li ◽  
...  

2014 ◽  
Vol 34 (suppl_1) ◽  
Author(s):  
Jessilyn Dunn ◽  
Haiwei Qiu ◽  
Soyeon Kim ◽  
Daudi Jjingo ◽  
Ryan Hoffman ◽  
...  

Atherosclerosis preferentially occurs in arterial regions of disturbed blood flow (d-flow), which alters gene expression, endothelial function, and atherosclerosis. Here, we show that d-flow regulates genome-wide DNA methylation patterns in a DNA methyltransferase (DNMT)-dependent manner. We found that d-flow induced expression of DNMT1, but not DNMT3a or DNMT3b, in mouse arterial endothelium in vivo and in cultured endothelial cells by oscillatory shear (OS) compared to unidirectional laminar shear in vitro. The DNMT inhibitor 5-Aza-2’deoxycytidine (5Aza) or DNMT1 siRNA significantly reduced OS-induced endothelial inflammation. Moreover, 5Aza reduced lesion formation in two atherosclerosis models using ApoE-/- mice (western diet for 3 months and the partial carotid ligation model with western diet for 3 weeks). To identify the 5Aza mechanisms, we conducted two genome-wide studies: reduced representation bisulfite sequencing (RRBS) and transcript microarray using endothelial-enriched gDNA and RNA, respectively, obtained from the partially-ligated left common carotid artery (LCA exposed to d-flow) and the right contralateral control (RCA exposed to s-flow) of mice treated with 5Aza or vehicle. D-flow induced DNA hypermethylation in 421 gene promoters, which was significantly prevented by 5Aza in 335 genes. Systems biological analyses using the RRBS and the transcriptome data revealed 11 mechanosensitive genes whose promoters were hypermethylated by d-flow but rescued by 5Aza treatment. Of those, five genes contain hypermethylated cAMP-response-elements in their promoters, including the transcription factors HoxA5 and Klf3. Their methylation status could serve as a mechanosensitive master switch in endothelial gene expression. Our results demonstrate that d-flow controls epigenomic DNA methylation patterns in a DNMT-dependent manner, which in turn alters endothelial gene expression and induces atherosclerosis.


Herz ◽  
2017 ◽  
Vol 43 (7) ◽  
pp. 656-662 ◽  
Author(s):  
X. Wang ◽  
A.-H. Liu ◽  
Z.-W. Jia ◽  
K. Pu ◽  
K.-Y. Chen ◽  
...  

2018 ◽  
Author(s):  
Yi Jin Liew ◽  
Emily J. Howells ◽  
Xin Wang ◽  
Craig T. Michell ◽  
John A. Burt ◽  
...  

MainThe notion that intergenerational or transgenerational inheritance operates solely through genetic means is slowly being eroded: epigenetic mechanisms have been shown to induce heritable changes in gene activity in plants1,2and metazoans1,3. Inheritance of DNA methylation provides a potential pathway for environmentally induced phenotypes to contribute to evolution of species and populations1–4. However, in basal metazoans, it is unknown whether inheritance of CpG methylation patterns occurs across the genome (as in plants) or as rare exceptions (as in mammals)4. Here, we demonstrate genome-wide intergenerational transmission of CpG methylation patterns from parents to sperm and larvae in a reef-building coral. We also show variation in hypermethylated genes in corals from distinct environments, indicative of responses to variations in temperature and salinity. These findings support a role of DNA methylation in the transgenerational inheritance of traits in corals, which may extend to enhancing their capacity to adapt to climate change.


Author(s):  
Mimansha Patel ◽  
Madhuri Nitin Gawande ◽  
Minal Shashikant Chaudhary ◽  
Alka Harish Hande

Background: “Oral Potentially Malignant Disorder (OPMD)” is a well-known symptom that, if untreated, can be carcinogenic. It includes leukoplakia, erythroplakia or erythroleukoplakia. One of the typical premalignant lesions of the oral cavity is “oral leukoplakias (OLs),” which frequently precedes “OSCCs.”OLs with dysplastic characteristics are considered to be at a higher risk of “malignant transformation.” So, early diagnosis of "oral squamous cell carcinomas (OSCCs)" is desperately required to enhance patient prognosis and quality of life (QOL).As a result, we examined the distinctive promoter methylation presence in high-risk OLs. Objectives: To detect, compare & correlate “DNA methylation” patterns in normal individuals, tobacco users without disease and tobacco users with the disease. Methodology: With the participants' full consent, 48 saliva samples were obtained and prepared. DNA isolation, restriction digestion of genomic DNA, extraction of restriction enzyme digested genomic DNA, Polymerase Chain Reaction (PCR), and Agarose Gel Electrophoresis (AGE) were all carried out. Expected results: This study will help us to assess the use of Saliva as an aid to identifying both high and low risk “Oral Potentially Malignant Disorders.” Conclusion: Peculiar promoter methylation of various genes was related to a high possibility of malignant transformation in OLs.


eLife ◽  
2019 ◽  
Vol 8 ◽  
Author(s):  
Shir Toubiana ◽  
Miriam Gagliardi ◽  
Mariarosaria Papa ◽  
Roberta Manco ◽  
Maty Tzukerman ◽  
...  

DNA methyltransferase 3B (DNMT3B) is the major DNMT that methylates mammalian genomes during early development. Mutations in human DNMT3B disrupt genome-wide DNA methylation patterns and result in ICF syndrome type 1 (ICF1). To study whether normal DNA methylation patterns may be restored in ICF1 cells, we corrected DNMT3B mutations in induced pluripotent stem cells from ICF1 patients. Focusing on repetitive regions, we show that in contrast to pericentromeric repeats, which reacquire normal methylation, the majority of subtelomeres acquire only partial DNA methylation and, accordingly, the ICF1 telomeric phenotype persists. Subtelomeres resistant to de novo methylation were characterized by abnormally high H3K4 trimethylation (H3K4me3), and short-term reduction of H3K4me3 by pharmacological intervention partially restored subtelomeric DNA methylation. These findings demonstrate that the abnormal epigenetic landscape established in ICF1 cells restricts the recruitment of DNMT3B, and suggest that rescue of epigenetic diseases with genome-wide disruptions will demand further manipulation beyond mutation correction.


Sign in / Sign up

Export Citation Format

Share Document